(Q44553382)

English

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose

scientific article published in September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Costa A

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Casamitjana R

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Casals E

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Alvarez L

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Morales J

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Masramón X

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hernández G

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gomis R

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Conget I

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

743-745

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00993.X

21 January 2018

Identifiers

10.1046/J.1464-5491.2003.00993.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44553382&oldid=2027708207"